S
ECONDHAND SMOKE (SHS) EXposure is associated with coronary heart disease (CHD) in nonsmokers, and a nonlinear dose relationship exists such that SHS exposure has a larger than expected adverse effect at low levels of exposure. 1 Research suggests that the cardiovascular effects of SHS are nearly as large as those with active smoking. 1 Indeed, the magnitude of endothelial dysfunction in nonsmokers approaches that noted in active smokers 2 and may be only partially reversible. 3 The 2006 US Surgeon General's Report 4 underscored the negative impact of SHS, stating that "exposure to SHS has immediate effects on the cardiovascular system." An estimated 46 000 nonsmoking Americans die annually from cardiovascular events related to SHS. 5 Eliminating smoking in public places holds potential for improving public health and reducing cardiovascular events beyond the expected impact of the reduction in active smoking. 6 Finding additional scientific data in support of smoke-free policies will help to ensure their continuation and encourage locales without such laws to consider them.
Several studies [7] [8] [9] [10] [11] [12] [13] [14] described a decline in hospital admissions for myocardial infarction (MI) after implementation of smokefree legislation, and a meta-analysis 15 of 17 published studies reported a 10% reduction in admissions for MI after the implementation of such legislation. An expert committee from the Institute of Medicine 16 concluded that "there is a causal relationship between smoking bans and de-creases in acute coronary events," but the committee did not determine the magnitude of the decrease in relative risk. The 10-member committee concluded that none of the studies to date was of ideal design. To evaluate the population effect of the implementation of smoke-free laws on cardiovascular events, we examined data from the Rochester Epidemiology Project, including individual patient data for MI cases validated using rigorous epidemiologic criteria and sudden cardiac death (SCD) in Olmsted County, Minnesota, before and after implementation of smoke-free workplace laws.
METHODS

STUDY SETTING
Olmsted County, located in southeastern Minnesota, has a population of 144 248 (86% white, 51% female). 17 Only a few providers (chiefly Mayo Clinic and Olmsted Medical Center) deliver nearly all medical care to county residents. Medical records used by each provider capture information for all encounters and can be retrieved from indices based on all diagnoses and procedures maintained by Mayo Clinic. 18 This results in the linkage of medical records from all sources of care, providing a unique infrastructure to analyze disease occurrence and outcomes at the population level. Potential cases identified through the Rochester Epidemiology Project can then be validated by applying standardized methods appropriate for each disease entity. This process has been implemented for extensive cardiovascular disease epidemiologic research. [19] [20] [21] [22] In Olmsted County, a smoke-free restaurant law that did not include bars or other workplaces (Ordinance 1) was implemented on January 1, 2002, and on October 1, 2007, all workplaces (including bars) became smoke-free (Ordinance 2).
ASCERTAINMENT OF MI
Potential cases of MI included patients admitted to Olmsted County hospitals whose diagnosis was assigned the International Classification of Disease, Ninth Revision code 410 (acute MI). Infarctions were validated after manual data collection of relevant information and using algorithms integrating cardiac pain as well as electrocardiographic (ECG) and biomarker data (creatine kinase and MB fraction of creatine kinase). 23, 24 Biomarker values were recorded for up to 3 measurements on each of the first 3 days after admission or MI onset, if the patient was already hospitalized. 25, 26 All biomarkers were measured with a sandwich electrochemiluminescence immunoassay (Elecsys 2010; Roche Diagnostics Corporation) in the certified laboratories of the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, with robust quality control in place. Three ECGs per episode were coded using the Minnesota Code Modular ECG Analysis System. 27 Only first-ever MIs were considered as incident. All MIs were continuously abstracted for the duration of this study. These methods have been used in the Rochester Epidemiology Project coronary disease surveillance work for more than a decade, with excellent reliability. 23, 25, 28 
ASCERTAINMENT OF SCD
Our methods of ascertaining SCD have been published. 22, 29 In brief, SCD was defined as out-of-hospital deaths with the primary cause of death classified as CHD on the death certificate (International Classification of Diseases, Ninth Revision codes 410-414).
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CLINICAL DATA
Baseline demographic and clinical characteristics were collected from the medical records by nurse abstractors at the time of MI diagnosis or SCD. Clinicians' diagnoses were used to define hypertension, hyperlipidemia, diabetes mellitus, familial CHD, and smoking status. Body mass index was calculated as weight in kilograms divided by height in meters squared.
SMOKING PREVALENCE AND OTHER CARDIOVASCULAR RISK FACTORS
We used Behavioral Risk Factor Surveillance System (BRFSS) data from Minnesota adults for self-reported current smoking prevalence, hypercholesterolemia, diabetes mellitus, hypertension, and obesity (body mass index, Ն30). 30 The BRFSS is a state-based system of health surveys collecting information on health risk behaviors, preventive health practices, and health care access primarily related to chronic disease and injury. Telephone interviews are conducted with more than 350 000 adults in all 50 states, the District of Columbia, and US territories. 31 No Olmsted County-specific data for these risk factors exist.
STATISTICAL ANALYSIS
Unadjusted and age-and sex-adjusted incidence rates of MI and SCD were calculated for 18 months before and 18 months after implementation of each smoking law. The counts of events were used as the numerators, and the denominators were the Olmsted County population as determined by census data for the years 1990, 2000, and 2010, with linear interpolation for intercensal years. Adjusted rates were directly standardized to the age and sex distribution of the 2000 US population. Calculation of standard errors and 95% CIs was based on the Poisson error distribution. Differences in incidence in the 18 months before and after implementation of each law were assessed with Poisson regression, adjusting for age and sex and using an indicator variable with a value of 0 or 1 for the 18 months before and after the law, respectively. Specific counts for each period, age, and sex were used as the unit of observation, with the period-, age-, and sexspecific Olmsted County population as the offset. Interactions between age and period were assessed to determine whether changes in incidence rates were dependent on age. In all cases, no significant interactions were detected.
Cause of death was missing for 128 (3.7%) of the 3480 persons who died out-of-hospital during the 18 months before and after each smoke-free ordinance. To account for these missing data, multiple imputation methods were used to create 5 complete imputed data sets. 32 Analyses were performed for each imputed data set, and the results were combined using Rubin rules. 33 Nonlinear trends were explored using data from all years from 1995 to 2009. For these analyses, Poisson regression models were generated with the use of generalized additive models 34 with calendar year as a smoothed term. Analyses were performed using commercial software (SAS, version 9.2; SAS Institute Inc) and R (http://www.R-project .org). All aspects of the study were approved by the Mayo Clinic institutional review board.
RESULTS
PATIENT CHARACTERISTICS
During the 18 months before and after implementation of each smoke-free ordinance, there was a total of 717 incident cases of MI and 514 people who experienced SCD. Demographic and clinical characteristics of the patients are reported in Table 1 . No characteristics were found to differ significantly between the before and after ordinance periods, except for hyperlipidemia in persons experiencing SCD before and after Ordinance 1 (36.4% vs 54.0%, respectively; P = .004).
INCIDENCE OF MI
The age-and sex-adjusted rate of MI was 150.8 per 100 000 (95% CI, 129.0-172.6) for the 18 months before Ordinance 1 and 144.6 per 100 000 (95% CI, 123.6-165.5) for the 18 months after Ordinance 1 ( Table 2 ). The incidence of MI did not significantly decline during this period (age-and sex-adjusted relative risk [RR], 0.96; 95% CI, 0.78-1.18; P = .71).
Conversely, for the period surrounding Ordinance 2, the incidence of MI adjusted for age and sex declined from 152.3 per 100 000 (95% CI, 131.4-173.3) to 100.7 per 100 000 (95% CI, 83.8-117.5). This equated to a 34% decline over the 18 months before and after implementation of Ordinance 2 (adjusted RR, 0.66; 95% CI, 0.53-0.82; P Ͻ .001). Over the entire study period comparing 18 months before Ordinance 1 and 18 months after Ordinance 2, we observed a 33% decline in the incidence of MI (adjusted RR, 0.67; 95% CI, 0.53-0.83; P Ͻ .001).
The annual unadjusted MI incidence rates from 1995 to 2009 are presented in Figure 1 . A smoothing spline with 95% CI is superimposed on the actual rates. The test for nonlinearity was significant (P = .009), with an inflection point occurring around 2006.
INCIDENCE OF SCD
No decline in SCD was observed for the 18 months before and after Ordinance 1 (adjusted RR, 1.01; 95% CI, 0.80-1.27; P = .96), with the age-and sex-adjusted rates of SCD being 109.1 per 100 000 (95% CI, 91.0-127.2) and 112.7 per 100 000 (95% CI, 94.3-131.0), respectively (Table 2) . Similarly, there was not a significant change in rates of SCD 18 months before Ordinance 2 compared with 18 months after Ordinance 2 (adjusted RR, 1.17; 95% CI, 0.91-1.51; P = .22). The age-and sex-adjusted rates of SCD were 78.8 per 100 000 (95% CI, 64.0-93.5) 18 months before the ordinance and 92.0 per 100 000 (95% CI, 75.7-108.3) 18 months after the ordinance. There was a 17% decline in the incidence of SCD for the overall study period comparing the 18 months before Ordinance 1 with the 18 months after Ordinance 2 (adjusted RR, 0.83; 95% CI, 0.65-1.06; P = .13).
The annual SCD rates from 1995 to 2009 are presented in Figure 1 . A smoothing spline with 95% CI is superimposed on the unadjusted rates. No significant difference was found in the test for nonlinearity (P = .09). 
SMOKING PREVALENCE AND OTHER CARDIOVASCULAR RISK FACTORS
Based on the Minnesota BRFSS data, 30 the self-reported smoking prevalence among adults decreased from 19.8% in 2000 to 14.9% in 2010. During the same period, the prevalence of diabetes mellitus and obesity increased, and the prevalence of hypertension and hypercholesterolemia remained flat (Figure 2 and Figure 3) .
COMMENT
We report a substantial decline in the incidence of MI from 18 months before the smoke-free restaurant law was implemented to 18 months after the comprehensive smoke-free workplace law was implemented 5 years later. This decrease in the incidence of MI is similar to the 40% decrease in the first report in Helena, Montana. 7 In a large study 14 that included biomarker confirmation, the rate of admission to Scottish hospitals decreased by 19% after a smoke-free workplace law was implemented. This study was limited by its inclusion of only 9 hospitals, which accounted for 64% of the country's hospital admissions; thus, the rates were not true incidence rates, and the time frame was much shorter than ours.
The mechanisms of the deleterious effect of SHS are diverse. As few as 5 minutes of exposure to SHS in nonsmokers reduces aortic distensibility, 35 and abdominal aortic stiffness is increased with SHS exposure in children. 36 In nonsmokers, 30 minutes of SHS exposure produces an abrupt and dramatic reduction in coronary artery flow velocity reserve. 37 Thirty minutes of SHS exposure leads to vascular injury characterized by mobilization of dysfunctional endothelial progenitor cells with blocked nitric oxide production, which is essential to endothelial function because its release mediates vasodilatation. 38 Exposure to SHS in nonsmokers has been associated with lower high-density lipoprotein cholesterol levels, increased markers of inflammation, increased serum fibrinogen and homocysteine, decreased antioxidant levels, and increased insulin resistance.
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CAUSAL INFERENCE
Although it does not embody the "ideal design" as described by the Institute of Medicine report, 16 our study addresses some key limitations by reporting data from a defined community with a large sample size and a prolonged period of observation. Because our data constitute before vs after comparisons in the absence of a comparison geographic area in which no smoke-free law has been implemented, its interpretation should also explicitly consider alternative causes of changes in MI incidence. To this end, the new diagnostic criteria for MI were deployed in 2000; these new criteria increased the number of MIs included 25, 26 and thus could mask a decline in incidence. The results of the present study, however, are not contaminated by the change in biomarkers, since all MIs were confirmed with creatine kinase and the MB band of creatine kinase. No concurrent intervention could explain the trends observed during the period of the study. In particular, although automated external defibrillators have been increasingly used in Rochester, Minnesota, the concurrent incidence of out-of-hospital cardiac arrest associated with ventricular fibrillation had begun to level before implementation of the first smoke-free law. 44 Furthermore, the prevalence of smoking declined (Figure 2 ) and the rate of hypertension and hypercholesterolemia remained essentially constant, whereas the rate of diabetes mellitus and obesity increased (Figure 3 ). 30 Finally, one important consideration is the interpretation of the trends reported herein in light of secular trends. Although the incidence of SCD has been declining over the past 30 years, the decrease in the incidence of SCD and MI accelerated during the period of the implementation of these smoke-free workplace laws. There were other tobacco control activities in Minnesota during the time of this study, including a 2001 mass media campaign focused on helping smokers to stop smoking, using a tobacco quitline or clinic services Although the determinants of the secular trend in the incidence of MI and SCD cannot be determined with certainty in ecologic analysis, particularly with concomitant tobacco control activities, the acceleration of the trends (nonlinearity of the smoothing spline analysis for MI), while all other cardiovascular risk factors (except smoking prevalence) were either stable or increasing, supports the critical role of smoke-free workplace laws in tobacco control efforts. The impact of smoke-free legislation is multifold: reducing the intensity of smoking among smokers, increasing quit rates, reducing smoking startup by teenagers, and reducing exposure to SHS. Thus, the impact can be expected to occur over a period before and after implementation. Previous trends in the incidence of MI in Olmsted County were stable between 1987 and 2006. 26 Herein, we report that MI incidence did not change significantly during the 18 months before and the 18 months after Ordinance 1 (July 2000 to June 2003) was implemented, which is consistent with these previously published data. Thereafter, there was a substantial decline in MI incidence from the 18 months before compared with the 18 months after Ordinance 2 (April 2006 to March 2009) was implemented, pointing to a notable discontinuity of the MI trends, within a period during which no other obvious factor could have plausibly played a large role. 
LIMITATIONS AND STRENGTHS
Some limitations should be discussed to aid in the interpretation of the data. We examined temporal trends in MI and SCD concomitant to the implementation of smokefree laws. This design is consistent with a natural experiment with its well-known limitation regarding causal inference. We recognize that misclassification of deaths occurs in death certificates; however, the study focuses on temporal trends that are unlikely to be confounded by the classification of deaths. We do not have countyspecific prevalence data for smoking or other risk factors; however, the trends in Olmsted County are usually consistent with those observed in the Minnesota data (Figures 2 and 3) . 30 The population of Olmsted County is primarily white, and further studies are needed in communities of more diverse racial and ethnic composition. Furthermore, we do not have self-reported exposure to SHS or biochemical markers of SHS exposure, although we expect results similar to those of the Scottish study, 14 in which self-reported SHS exposure, confirmed by salivary cotinine, decreased after the smoke-free law was implemented.
Our study has several major strengths. It was conducted under the auspices of the Rochester Epidemiology Project, which has a long track record (Ͼ50 years) of robust epidemiologic studies. Our results reflect a complete enumeration of the cases of MI and SCD in a welldefined community; in particular, all MI and SCD cases were validated using rigorous epidemiologic criteria. 25, 29 The period during which this study was conducted is longer than that reported in most published studies, thereby affording greater power to detect significant trends.
CLINICAL AND PUBLIC HEALTH IMPLICATIONS
We believe that SHS could be considered a major risk factor for MI, joining family history, hypertension, hyperlipidemia, diabetes mellitus, and low physical activity. Hence, all clinicians should ascertain SHS exposure and promote the elimination of SHS exposure as part of their lifestyle recommendations. 46 Furthermore, all clinicians should be encouraged to become advocates for effective tobacco control policies, such as increased taxes, graphic labeling, smoke-free workplaces, and marketing and advertising restrictions, since smoking and SHS exposure are responsible for 10% of all cardiovascular deaths globally. 47 Sudden cardiac death represents 60% of all deaths from CHD, and most occur in people without a CHD diagnosis who do not meet high-risk criteria as defined by clinical trials and cohort studies. 48 Thus, the prevention of SCD hinges on public health interventions focused on the primary prevention of CHD or the wider availability of automated external defibrillators and implantable cardioverter-defibrillators. We observed a statistically nonsignificant decline in the incidence of SCD, which may reflect the relatively smaller number of events in the SCD group. These findings suggest that SHS exposure could be a risk factor for SCD. Because this risk factor is highly modifiable, the expansion of smoke-free workplace policies could have a major public health impact by reducing the incidence of SCD.
In conclusion, the implementation of smoke-free workplace ordinances was associated with a substantial decrease in MI, the magnitude of which is not explained by concomitant community interventions or changes in cardiovascular risk factors, with the exception of smoking prevalence. Exposure to SHS should be considered a modifiable risk factor for MI. All people should avoid SHS exposure as much as possible, and those with CHD should have no exposure to SHS.
